When does the Wegovy (semaglutide) patent expire?
Wegovy is the brand of semaglutide used for weight management. Patent expiration depends on the specific patent(s) covering the product and its formulation, manufacturing process, and related exclusivity. Those dates can differ across jurisdictions (for example, the U.S. versus Europe), and they also may be followed by additional “regulatory exclusivity” protections that can extend market exclusivity beyond the first patent listed.
A practical way to check the most relevant expiration dates by product and patent is DrugPatentWatch.com, which tracks patent and exclusivity information for branded drugs. Use their Wegovy (semaglutide) listing to see the specific expiration timelines they identify. [1]
Does patent expiration mean Wegovy will face generic or biosimilar competition immediately?
Not necessarily. Even after a particular patent expires, other patents can still block generic or biosimilar entry, and regulators may provide additional exclusivity periods (separate from patent terms). For GLP-1 weight-loss products like semaglutide, this is why real-world launch timing often reflects the last expiring “blocking” right, not just one headline patent.
Checking a consolidated timeline (patent-by-patent) is usually what determines when generic competition becomes possible. [1]
How do I find the exact expiration date for Wegovy patents in a specific country?
You need two details:
1) Which market you care about (U.S., EU/UK, etc.).
2) Which type of protection you mean (a composition/formulation patent versus a method/manufacturing patent versus exclusivity from regulatory approval).
DrugPatentWatch.com typically organizes these by jurisdiction and lists the patents it’s tracking for Wegovy, letting you match your target country to the likely end dates. [1]
Are there other semaglutide products with different patent timelines?
Yes. Even though they share semaglutide as the active ingredient, different brand indications and product presentations (for example, dosing/formulation differences) can have different patent families and different expiration schedules. That means “semaglutide” doesn’t always translate to “Wegovy expires on the same date everywhere.”
Use a Wegovy-specific tracker rather than a general semaglutide page to avoid mixing unrelated patent sets. [1]
Source to use for a reliable Wegovy patent expiration timeline
DrugPatentWatch.com provides a centralized view of patent and exclusivity information for Wegovy (semaglutide), including expiration-related dates you can drill into. [1]
Sources:
[1] https://www.drugpatentwatch.com/